Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 29, 2024Current OncologyOpen Access

Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review

View Full Paper
Ask AI
Bookmark
Share

Authors

SMS. MortuzaBCBenjamin Chin‐YeeTJTyler E. James

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mortuza et al. (2024) studied this question.

synapsesocial.com/papers/68e71cb7b6db64358769604fhttps://doi.org/10.3390/curroncol31040134
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases2024 · 1 citations
  2. 2Data from Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts.2024
  3. 3Validation and comparison of 5th edition World Health Organization classification (<scp>WHO</scp> 2022) and International Consensus Classification proposals for MDS‐<i>SFB31</i>2024
  4. 4Supplementary Figure S3 from Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts.2024
  5. 5Supplementary Figure S3 from Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts.2024